Human Rct
Controlled human trial evidence. We still check sample size, endpoints, population and replication.
LHN separates evidence type from claim strength. A human RCT can still be too small or too indirect for a broad longevity claim, and a mechanism can be important without proving a consumer outcome.
Controlled human trial evidence. We still check sample size, endpoints, population and replication.
Human association data. Useful for signals, weaker for causal claims.
A trial exists or is registered. Registration is not proof of benefit.
Animal evidence. Important for biology, not enough for human consumer claims by itself.
Mechanistic plausibility without direct human outcome evidence.
User reports or forum discussion. Useful as demand signal, not evidence of efficacy.
Agency action, label, warning, meeting or registry signal.
A product, clinic or marketing claim that needs independent verification.
Insufficient source clarity to classify confidently.